[Reduction of low weight birth, premature amniotic rupture and premature labor following additional magnesium therapy in high risk pregnancy treated with beta mimetics and cerclage].
D000328:Adult; D000367:Age Factors; D002976:Clenbuterol / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000517:prevention & control; D005860:Germany, West; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008274:Magnesium / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010298:Parity; D010927:Placental Insufficiency / Q000453:epidemiology; D011247:Pregnancy; D002581:Uterine Cervical Incompetence / Q000601:surgery
D004983:Ethanolamines; D008274:Magnesium; D002976:Clenbuterol
Reduzierung der Mangelgeburt sowie der vorzeitigen Amnionruptur und Frühgeburt nach Magnesium-Zusatztherapie bei Betamimetika/Cerclage-behandelten Risiko-Schwangerschaften.